Murdock, Shen, Griffin, Kelley-Loughnane, Papautsky, Hagen: "Optimization of a paper-based ELISA for a human performance biomarker." in: Analytical chemistry, Vol. 85, Issue 23, pp. 11634-42, (2013) (PubMed).
Rylkova, Boissoneault, Isaac, Prado, Shah, Bruijnzeel: "Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats." in: Neuropeptides, Vol. 42, Issue 3, pp. 215-27, (2008) (PubMed).
The C-terminal NPY fragment (13-36) [NPY-(13-36)], a Y2 receptor agonist, elicits vasopressor responses upon central administration. The cardiovascular responses of NPY-(13-36), together with the distribution of NPY receptor subtypes within the nucleus tractus solitarius (nTS), have been studied in spontaneously hypertensive rats (SHR). Neuropeptide Y (13-36) (NPY 13-36) stimulates both Y2 and Y5 NPY receptor subtypes, but causes no increase in food intake even when injected at high doses, while the full-length NPY is one of the most potent physiological stimulants of feeding yet described. NPY 13-16 inhibits retinotectal transfer in amphibians.